Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:IRMD NASDAQ:SGHT NASDAQ:SIBN NASDAQ:SMLR On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeIRMDiRadimed$56.69-1.3%$57.62$42.34▼$63.29$720.81M0.9144,166 shs30,893 shsSGHTSight Sciences$3.50-1.1%$3.80$2.03▼$8.45$180.94M2.47207,279 shs80,708 shsSIBNSiBone$16.62-0.7%$18.22$11.70▼$20.05$708.26M0.93391,531 shs296,134 shsSMLRSemler Scientific$41.24-5.4%$38.38$21.77▼$81.56$564.49M1.39580,570 shs622,725 shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceIRMDiRadimed0.00%-1.53%-3.01%+9.50%+22.76%SGHTSight Sciences0.00%+2.64%-18.03%+31.58%-57.11%SIBNSiBone0.00%-3.37%-0.36%+20.00%-2.86%SMLRSemler Scientific0.00%-9.42%+29.12%+26.93%+13.89%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationIRMDiRadimed4.5167 of 5 stars3.53.02.54.40.03.31.9SGHTSight Sciences1.5775 of 5 stars2.12.00.00.01.83.30.6SIBNSiBone3.8423 of 5 stars3.52.00.03.31.22.50.6SMLRSemler Scientific2.7165 of 5 stars3.72.00.00.03.12.50.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceIRMDiRadimed 3.00Buy$72.0027.01% UpsideSGHTSight Sciences 2.29Hold$3.9312.38% UpsideSIBNSiBone 3.00Buy$22.5035.38% UpsideSMLRSemler Scientific 3.33Buy$89.00115.81% UpsideCurrent Analyst Ratings BreakdownLatest SGHT, IRMD, SIBN, and SMLR Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/15/2025SGHTSight SciencesMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$3.00 ➝ $4.007/9/2025SMLRSemler ScientificMaxim GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy$95.007/8/2025SMLRSemler ScientificBenchmarkSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$101.006/18/2025SGHTSight SciencesPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral$3.50 ➝ $4.005/22/2025SGHTSight SciencesCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral$3.20 ➝ $3.605/9/2025SGHTSight SciencesLake Street CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetHold ➝ Hold$2.50 ➝ $3.005/6/2025SIBNSiBoneTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$20.00 ➝ $22.005/6/2025SIBNSiBoneCantor FitzgeraldSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$25.00 ➝ $25.005/6/2025SIBNSiBoneNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$24.00 ➝ $24.00(Data available from 7/20/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookIRMDiRadimed$73.24M9.85$1.58 per share35.83$6.85 per share8.28SGHTSight Sciences$78.11M2.32N/AN/A$1.72 per share2.03SIBNSiBone$167.18M4.24N/AN/A$3.98 per share4.18SMLRSemler Scientific$49.23M11.47$4.48 per share9.21$24.90 per share1.66Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateIRMDiRadimed$19.23M$1.5536.5728.35N/A26.33%23.28%20.59%7/30/2025 (Estimated)SGHTSight Sciences-$51.51M-$0.98N/AN/AN/A-63.24%-54.62%-34.92%7/30/2025 (Estimated)SIBNSiBone-$30.91M-$0.64N/AN/AN/A-15.03%-16.00%-11.69%8/4/2025 (Estimated)SMLRSemler Scientific$40.90M-$2.61N/A∞N/A-60.69%19.75%15.47%8/4/2025 (Estimated)Latest SGHT, IRMD, SIBN, and SMLR EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/7/2025Q2 2025IRMDiRadimed$0.45N/AN/AN/AN/AN/A8/7/2025Q2 2025SGHTSight Sciences-$0.25N/AN/AN/A$18.18 millionN/A8/4/2025Q2 2025SIBNSiBone-$0.19N/AN/AN/A$48.12 millionN/A5/13/2025Q1 2025SMLRSemler ScientificN/A-$0.76N/A-$6.74N/A$8.84 million5/8/2025Q1 2025SGHTSight Sciences-$0.29-$0.28+$0.01-$0.28$16.51 million$17.51 million5/5/2025Q1 2025SIBNSiBone-$0.24-$0.15+$0.09-$0.15$45.13 million$47.29 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthIRMDiRadimed$0.681.20%N/A43.87%1 YearsSGHTSight SciencesN/AN/AN/AN/AN/ASIBNSiBoneN/AN/AN/AN/AN/ASMLRSemler ScientificN/AN/AN/AN/AN/ALatest SGHT, IRMD, SIBN, and SMLR DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/5/2025IRMDiRadimedquarterly$0.171.3%5/20/20255/20/20255/30/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioIRMDiRadimedN/A8.877.62SGHTSight Sciences0.5110.479.99SIBNSiBone0.218.537.26SMLRSemler Scientific0.590.520.51Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipIRMDiRadimed92.34%SGHTSight Sciences55.51%SIBNSiBone98.11%SMLRSemler Scientific49.37%Insider OwnershipCompanyInsider OwnershipIRMDiRadimed36.80%SGHTSight Sciences30.90%SIBNSiBone4.00%SMLRSemler Scientific30.20%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableIRMDiRadimed11012.72 million8.04 millionOptionableSGHTSight Sciences21051.70 million35.72 millionOptionableSIBNSiBone35042.62 million40.91 millionOptionableSMLRSemler Scientific12013.69 million9.55 millionNot OptionableSGHT, IRMD, SIBN, and SMLR HeadlinesRecent News About These CompaniesSMLR Investor News: If You Have Suffered Losses in Semler Scientific, Inc. (NASDAQ: SMLR), You Are Encouraged to Contact The Rosen Law Firm About Your RightsJuly 20 at 7:41 AM | globenewswire.comPrincipal Financial Group Inc. Sells 55,102 Shares of Semler Scientific Inc. (NASDAQ:SMLR)July 19 at 3:08 AM | marketbeat.comRosen Law Firm Encourages Semler Scientific, Inc. Investors to Inquire About Securities Class Action Investigation - SMLRJuly 18 at 5:36 PM | prnewswire.comSemler Scientific Advances to 14th-Largest Public Bitcoin Holder Following $25 Million InvestmentJuly 18 at 2:36 AM | coinspeaker.comSemler Scientific Becomes 14th-Largest Public Bitcoin Holder After $25M BTC BuyJuly 18 at 2:36 AM | finance.yahoo.comSMLR Investor News: If You Have Suffered Losses in Semler Scientific, Inc. (NASDAQ: SMLR), You Are Encouraged to Contact The Rosen Law Firm About Your RightsJuly 17 at 6:59 PM | globenewswire.com9,970 Shares in Semler Scientific Inc. (NASDAQ:SMLR) Purchased by Alps Advisors Inc.July 16, 2025 | marketbeat.comSemler Scientific (NASDAQ:SMLR) Trading Down 8.2% - Here's What HappenedJuly 15, 2025 | marketbeat.com135 Public Companies That Hold Bitcoin — And Why It MattersJuly 15, 2025 | schaeffersresearch.comSemler Scientific Inc (SMLR) - Investing.comJuly 12, 2025 | investing.comSemler Scientific (NASDAQ:SMLR) Rating Increased to Strong-Buy at Maxim GroupJuly 12, 2025 | americanbankingnews.comSMLR Investor News: If You Have Suffered Losses in Semler Scientific, Inc. (NASDAQ: SMLR), You Are Encouraged to Contact The Rosen Law Firm About Your RightsJuly 11, 2025 | globenewswire.comSemler Scientific (NASDAQ:SMLR) Research Coverage Started at BenchmarkJuly 11, 2025 | americanbankingnews.comSemler Scientific (NASDAQ:SMLR) Stock Price Up 8% - Here's What HappenedJuly 10, 2025 | marketbeat.comMaxim Group Initiates Coverage of Semler Scientific (SMLR) with Buy RecommendationJuly 10, 2025 | msn.comSemler Scientific Stock Gets Relative Strength Rating UpgradeJuly 9, 2025 | msn.comSemler Scientific (NASDAQ:SMLR) Now Covered by Maxim GroupJuly 9, 2025 | marketbeat.comBenchmark Initiates Coverage of Semler Scientific (SMLR) with Buy RecommendationJuly 9, 2025 | msn.comSMLR Investor News: If You Have Suffered Losses in Semler Scientific, Inc. (NASDAQ: SMLR), You Are Encouraged to Contact The Rosen Law Firm About Your RightsJuly 8, 2025 | globenewswire.comSemler Scientific (NASDAQ:SMLR) Coverage Initiated by Analysts at BenchmarkJuly 8, 2025 | marketbeat.comRosen Law Firm Encourages Semler Scientific, Inc. Investors to Inquire About Securities Class Action Investigation - SMLR - MorningstarJuly 7, 2025 | morningstar.comMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeSGHT, IRMD, SIBN, and SMLR Company DescriptionsiRadimed NASDAQ:IRMD$56.69 -0.76 (-1.32%) Closing price 07/18/2025 04:00 PM EasternExtended Trading$56.52 -0.16 (-0.29%) As of 07/18/2025 06:27 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.Sight Sciences NASDAQ:SGHT$3.50 -0.04 (-1.13%) Closing price 07/18/2025 04:00 PM EasternExtended Trading$3.50 +0.00 (+0.14%) As of 07/18/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. It operates through two segments, Surgical Glaucoma and Dry Eye. The company's products include OMNI Surgical System, an implant-free glaucoma surgery technology indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma; and SION Surgical Instrument, a manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. It also offers TearCare System, a wearable eyelid technology for adult patients with evaporative dry eye disease due to meibomian gland dysfunction, as well as related components. It offers its products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States. Sight Sciences, Inc. was incorporated in 2010 and is headquartered in Menlo Park, California.SiBone NASDAQ:SIBN$16.62 -0.11 (-0.66%) Closing price 07/18/2025 04:00 PM EasternExtended Trading$16.63 +0.01 (+0.06%) As of 07/18/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.SI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.Semler Scientific NASDAQ:SMLR$41.24 -2.36 (-5.41%) Closing price 07/18/2025 04:00 PM EasternExtended Trading$41.32 +0.08 (+0.19%) As of 07/18/2025 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. It also offers Insulin Insights, a software program that is used by a healthcare provider to optimize outpatient insulin dosing. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, family practitioners, healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups and retailers. It offers its products through sales representatives and distributors. The company was incorporated in 2007 and is headquartered in Santa Clara, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 07/14 - 07/18 Netflix Q2 2025 Earnings: What Investors Need to Know High-Flying GE Aerospace Drops After Blowout Q2 — What Now? A New $70 Billion AI Investment Could Push Taiwan Semiconductor Why Prologis May Be the Smartest Backdoor Bet on AI Real Estate Snap-On: Snap Up This Strong Signal While It’s Still Cheap Why Abbott Laboratories Is a Q2 2025 Buy: Growth & Yield Why Pure Storage Is a Core Investment for the AI Era Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
